EFAVIRENZ Emtricit-Tenof-Mepha Lactab bte 30 pce

7680662170018 CH-66217 J05AR06 08.03.0.
EFAVIRENZ Emtricit-Tenof-Mepha Lactab bte 30 pce
EFAVIRENZ Emtricit-Tenof-Mepha Lactab bte 30 pce
EFAVIRENZ Emtricit-Tenof-Mepha Lactab bte 30 pce
1 / 3
google

Details

Product number
6621701
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
efavirenzum 600 mg, emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili phosphas, cellulosum microcristallinum, carmellosum natricum conexum, mannitolum, hydroxypropylcellulosum, poloxamerum 407, crospovidonum, hypromellosum, hydroxypropylcellulosum substitutum humile, oleum vegetabile hydrogenatum, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 120, pro compresso obducto corresp. natrium 7.23 mg.

Articles (1)

Efavirenz-Emtricitabin-Tenofovir-Mepha 600 mg, 200 mg, 245 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/09/2024
Patient information leaflet
Français
17/09/2024
Patient information leaflet
Italien
17/09/2024
Professional SmPC
Allemand
17/09/2024
Professional SmPC
Français
17/09/2024
Professional SmPC
Italien
17/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
600.0 MG Substance Wirkstoff (Principe actif)
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
245.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
7.23 MG Substance HBESI

Reimbursement information

Public price
CHF 588.50
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2021

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66217
Drug name
Efavirenz-Emtricitabin-Tenofovir-Mepha, Filmtablette
Galenic form
FILM
ATC Code
J05AR06
Authorization status
Z
Dispensation category
A
First authorization
18/07/2017
Authorization expiration date
31/12/9999
IT number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektionen

Packaging details

Description (FR)
EFAVIRENZ Emtricit-Tenof-Mepha Lactab bte 30 pce
Description (DE)
EFAVIRENZ Emtricit-Tenof-Mepha Lactab Ds 30 Stk
Market launch
18/07/2017
Narcotic (BTM)
No

Other packaging sizes